Article
Neuroblastoma signalling models unveil combination therapies targeting feedback-mediated resistance
2021-06-14
Abstract excerpt
Very high risk neuroblastoma is characterised by increased MAPK signalling, and targeting MAPK signalling is a promising therapeutic strategy. We used a deeply characterised panel of neuroblastoma cell lines and found that the sensitivity to MEK inhibitors varied drastically between these cell lines. By generating quantitative perturbation data and mathematical modelling, we determined potential resistance mechani...
Topics
Open a Topic to create a Post that cites this publication.
Identifiers and source
- Literature Corpus work
- ca282f89-f0c8-5ceb-af4e-60f8e287b6b7
- DOI
- 10.1101/2021.06.14.448322
